CervoMed Inc. (CRVO)
NASDAQ: CRVO · Real-Time Price · USD
4.540
+0.430 (10.46%)
At close: Mar 9, 2026, 4:00 PM EDT
4.760
+0.220 (4.85%)
After-hours: Mar 9, 2026, 7:07 PM EDT
CervoMed Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 42 | 19 | 43 | - | - |
| Market Cap Growth | 118.90% | -55.39% | - | - | - |
| Enterprise Value | 15 | -27 | 33 | - | - |
| Last Close Price | 4.54 | 2.34 | 7.63 | - | - |
| PS Ratio | 6.82 | 1.98 | 6.06 | - | - |
| PB Ratio | 1.61 | 0.49 | 5.87 | - | - |
| P/TBV Ratio | 1.61 | 0.49 | 5.87 | - | - |
| EV/Sales Ratio | 2.39 | - | 4.60 | - | - |
| Debt / Equity Ratio | - | - | - | -1.38 | -2.74 |
| Net Debt / Equity Ratio | -1.05 | -0.99 | -1.06 | -0.92 | -0.92 |
| Asset Turnover | 0.16 | 0.37 | 1.01 | - | - |
| Quick Ratio | 6.23 | 10.61 | 3.36 | 0.31 | 1.48 |
| Current Ratio | 6.66 | 11.11 | 3.84 | 0.32 | 1.50 |
| Return on Equity (ROE) | -71.42% | -69.95% | - | - | - |
| Return on Assets (ROA) | -42.78% | -42.95% | -69.12% | -39.59% | - |
| Return on Capital Employed (ROCE) | -104.60% | -46.50% | -105.90% | 38.60% | -223.00% |
| Earnings Yield | -60.91% | -84.35% | -5.02% | - | - |
| Buyback Yield / Dilution | -19.30% | -203.34% | -413.65% | 88.49% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.